Every Form 4 that Mobia Medical, Inc. (MOBI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MOBI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MOBI filings page.
Mobia Medical, Inc. (MOBI) insider Chase C. Leavitt, the company’s General Counsel and Corporate Secretary, purchased 2,000 shares of common stock on September 11, 2026 in a purchase described as an open market or private transaction at $10.30 per share. Following this transaction, Leavitt directly holds 5,000 Mobia Medical common shares. No Rule 10b5-1 trading plan is reported for this transaction.
Mobia Medical, Inc. (MOBI) reported that Chief Operating Officer Prashant B. Rawat exercised stock options for 15,000 shares of common stock on September 2, 2026 at an exercise price of $3.38 per share. The exercised options were fully vested and exercisable and were converted into an equal number of common shares.
Following the transactions, Rawat holds 30,000 shares of Mobia Medical common stock directly and retains 167,243 stock options directly. No Rule 10b5-1 trading plan is reported for these transactions.
Mobia Medical, Inc. (MOBI) director Casey M. Tansey reported an open-market purchase of 16,441 shares of common stock on August 18, 2026 at a weighted average price of $12.0749 per share. Following this transaction, Tansey directly holds 318,332 shares of Mobia Medical common stock. The purchase price reflects multiple trades executed between $11.90 and $12.70 per share.
Mobia Medical, Inc. director Casey M Tansey reported open-market purchases of 68,559 shares of common stock over three days in August 2026. Transactions included 35,572 shares on August 13 at a weighted average price of $11.5073, 15,821 shares on August 14 at weighted average and fixed prices, and 17,166 shares on August 17 at a weighted average price of $11.8509. Footnotes state that several reported prices are weighted averages based on multiple trades within disclosed price ranges. The Rule 10b5-1 checkbox was not marked as an affirmatively adopted trading plan.
Mobia Medical, Inc. director Myriam Curet received two stock option awards on 2026-07-30: one for 19,740 options and another for 15,960 options, each exercisable for common stock at an exercise price of $11.1800 per share. The first option vests in three substantially equal annual installments on the first three anniversaries of the grant date; the second fully vests at the 2027 Annual Meeting under the Non-Employee Director Compensation Policy. Both options expire on 2036-07-30.
Mobia Medical, Inc. director Reza Zadno received two stock option awards covering 16,260 and 19,150 shares of common stock at an exercise price of $11.57 per share, expiring on July 14, 2036. Vesting schedules include three substantially equal annual installments and full vesting at the 2027 Annual Meeting.
Mobia Medical, Inc. insiders affiliated with Green Park & Golf Ventures entities reported multiple conversions of preferred stock and convertible notes into Common Stock on May 11, 2026. These were coded as derivative conversions rather than open‑market trades, so no shares were bought or sold for cash.
The filing shows various series of preferred stock and Convertible Notes automatically converted into Common Stock immediately before Mobia Medical’s initial public offering, pursuant to their terms. After these conversions, the reporting LLCs hold only Common Stock positions, all reported as indirect ownership.
Green Park & Golf Ventures II, LLC is the managing member of several holding LLCs, and its managers Clay M. Heighten, MD, Carl D. Soderstrom and Gilbert G. Garcia II share voting and dispositive power and may be deemed to beneficially own the converted shares.
Mobia Medical, Inc. disclosed that investment entities associated with Green Park & Golf Ventures Houston increased their indirect stake through a mix of preferred stock conversions and an open-market purchase. On May 11, 2026, these entities bought 60,537 shares of common stock at $15.00 per share in an open-market transaction.
In addition, shares of Series F, Series E-1 and Series E-2 Preferred Stock held by HTX MCT1–MCT4 investment LLCs were converted into common stock immediately prior to Mobia Medical’s initial public offering pursuant to their terms, including conversions into 126,005, 138,233, 83,579 and 38,875 common shares. Green Park & Golf Ventures Houston is the managing member of the HTX entities, and managers Clay M. Heighten, Carl D. Soderstrom and Gilbert G. Garcia II share voting and dispositive power over the converted shares.
Mobia Medical, Inc. reported that investment entities affiliated with Green Park & Golf Ventures II, LLC and related holders converted multiple preferred stock series, warrants and convertible notes into Common Stock, largely eliminating these derivatives immediately prior to the company’s initial public offering.
The filing shows conversions of Series B, Series D, Series F, Series E-1 and Series E-2 Preferred Stock into Common Stock, as well as Convertible Notes that converted into Common Stock under a formula based on the Offering price and pre‑offering valuation. A warrant to purchase Series B Preferred Stock was exercised, issuing Common Stock at an exercise price of $3.73744 per share with the warrant otherwise expiring on December 14, 2032.
In addition to these non‑cash conversions, an affiliated entity reported an open‑market purchase of 33,333 shares of Common Stock at $15.00 per share, increasing indirect holdings. All reported positions are held indirectly through LLCs managed by GPG Ventures II and its managers, who share voting and dispositive power over the securities.
Mobia Medical, Inc. reported a large restructuring of holdings by Green Park & Golf Ventures–affiliated investment entities around its initial public offering. Multiple series of preferred stock, warrants and convertible notes held by LLCs such as JCT, MTI 22, MTI 25, MTI 3-17, PHL and RM converted into Common Stock immediately before the offering, turning prior derivative positions into equity stakes.
As part of a cashless warrant exercise by RM, 6,731 shares of Common Stock were withheld to pay the exercise price and 159 shares were issued, so this disposition reflects tax/exercise mechanics rather than an open-market sale. Green Park & Golf Ventures II, LLC manages the LLC holders, and its managers Clay M. Heighten, Carl D. Soderstrom and Gilbert G. Garcia II may be deemed to share beneficial ownership of the resulting Common Stock positions.
Mobia Medical, Inc. reported insider activity involving large shareholders associated with Green Park & Golf Ventures. Entities linked to these investors purchased 81,000 shares of Common Stock in an open-market transaction at $15.00 per share, resulting in 81,000 indirectly held shares.
On the same date, 248,000 shares of Series C Preferred Stock were converted into 71,202 shares of Common Stock, eliminating the preferred position and creating an additional 71,202 indirectly held common shares. The footnotes explain that MTI 2015 Investment, LLC and GPG MOBI, LLC hold the securities, with Green Park & Golf Ventures II, LLC managing these entities and its managers sharing voting and dispositive power.
Mobia Medical, Inc. Chief Operating Officer Prashant B. Rawat exercised stock options to acquire 15,000 shares of common stock on June 10, 2026. The options were exercised at an exercise price of $3.38 per share, a routine derivative conversion rather than an open-market purchase or sale.
Following the transaction, Rawat directly holds 15,000 shares of common stock and continues to hold 182,243 stock options. The option grant vested 25% on June 27, 2023 and the remainder in 36 substantially equal monthly installments, reflecting standard compensation-related equity vesting.
Mobia Medical, Inc.'s Chief Financial Officer, Curnes Nelson Bunker, purchased 5,000 shares of common stock in an open‑market transaction at a weighted average price of $12.7938 per share on June 9, 2026. Following the purchase, he directly holds 366,997 shares.
The filing also reflects prior restructuring entries tied to entities such as Curnes Fund 2001 and Exceller Hunt Microtransponder 2017, LP, which distributed shares to their members before the company’s initial public offering. Footnotes state Bunker received 58,359 shares in these pro rata in‑kind distributions, which remain subject to IPO lock‑up restrictions.